Cruz-Torres, K.C.; Estrada-Soto, S.; Arias-Durán, L.; Navarrete-Vázquez, G.; Almanza-Pérez, J.C.; Mora-Ramiro, B.; Perea-Arango, I.; Hernández-Núñez, E.; Villalobos-Molina, R.; Carmona-Castro, G.;
et al. LC-MS Fingerprinting Development for Standardized Precipitate from Agastache mexicana, Which Induces Antihypertensive Effect through NO Production and Calcium Channel Blockade. Pharmaceutics 2023, 15, 2346.
https://doi.org/10.3390/pharmaceutics15092346
AMA Style
Cruz-Torres KC, Estrada-Soto S, Arias-Durán L, Navarrete-Vázquez G, Almanza-Pérez JC, Mora-Ramiro B, Perea-Arango I, Hernández-Núñez E, Villalobos-Molina R, Carmona-Castro G,
et al. LC-MS Fingerprinting Development for Standardized Precipitate from Agastache mexicana, Which Induces Antihypertensive Effect through NO Production and Calcium Channel Blockade. Pharmaceutics. 2023; 15(9):2346.
https://doi.org/10.3390/pharmaceutics15092346
Chicago/Turabian Style
Cruz-Torres, Karla Catalina, Samuel Estrada-Soto, Luis Arias-Durán, Gabriel Navarrete-Vázquez, Julio César Almanza-Pérez, Beatriz Mora-Ramiro, Irene Perea-Arango, Emanuel Hernández-Núñez, Rafael Villalobos-Molina, Gabriela Carmona-Castro,
and et al. 2023. "LC-MS Fingerprinting Development for Standardized Precipitate from Agastache mexicana, Which Induces Antihypertensive Effect through NO Production and Calcium Channel Blockade" Pharmaceutics 15, no. 9: 2346.
https://doi.org/10.3390/pharmaceutics15092346
APA Style
Cruz-Torres, K. C., Estrada-Soto, S., Arias-Durán, L., Navarrete-Vázquez, G., Almanza-Pérez, J. C., Mora-Ramiro, B., Perea-Arango, I., Hernández-Núñez, E., Villalobos-Molina, R., Carmona-Castro, G., Medina-Díaz, I.-M., & Ávila-Villarreal, G.
(2023). LC-MS Fingerprinting Development for Standardized Precipitate from Agastache mexicana, Which Induces Antihypertensive Effect through NO Production and Calcium Channel Blockade. Pharmaceutics, 15(9), 2346.
https://doi.org/10.3390/pharmaceutics15092346